Sponsors Seek One-Trial Approval Of Antibiotics For Drug-Resistant Bugs

Antibiotic developers are urging FDA to approve medicines to treat drug-resistant microbes on the basis of a single trial, with other supportive clinical and preclinical data to be used as substantiating evidence.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet